Search Results 201-210 of 23163 for B cell lymphomas

  1. Arushi Khurana, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

    ... lymphomas and cellular therapy. Her clinical and research focus includes: Expertise in management of various types of lymphomas such as diffuse large B-cell ...

  2. Arushi Khurana, M.B.B.S. - Mayo Clinic Faculty Profiles

    ... B-cell lymphoma, a common type of non-Hodgkin's lymphoma. This research focuses on identifying specific criteria and how they impact trial exclusion in ...

  3. CAR-T Cell Therapy Program - Department home - Mayo Clinic

    CAR-T cell therapy may be a treatment option for: Relapsed, refractory B-cell acute lymphoblastic leukemia; Relapsed, refractory B-cell non-Hodgkin's lymphoma ...

  4. Doctors and departments - Mayo Clinic

    ... B-cell lymphoma, the most common type of non-Hodgkin lymphoma. Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to ...

  5. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell ...

  6. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    ... lymphomas with CD30 expression that have not responded to treatment or have come back. The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL) ...

  7. Hematology - Clinical trials

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  8. Clinical trials - Oncology (Medical)

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  9. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy). Following ...

  10. Publications - David Li, M.D. - Mayo Clinic

    Intravascular Large B-cell Lymphoma Arising in a Spinal Hemangioma Hematopathology. 2023; 7(2). Iqbal M, Jiang L, Li KD, Moustafa MA, Kimbrough EO, Ansell SM, ...